Skip to main content
Premium Trial:

Request an Annual Quote

Thirteen-Member Proteomics Innovation Network Debuts This Week

Premium

Thirteen proteomics service and product providers have formed a new organization this week that aims to provide "sample to discovery" solutions for all stages of proteomics research, and to address "critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring," it said in a statement.

The group, called Proteomics Innovation Network, comprises: ProFACT Proteomics, Norton Scientific, Eprogen, Neolomed Biosciences, Focus Proteomics, New England Peptide, Ontario Cancer Biomarker Network, Innova Proteomics, Dualsystems Biotech, NewLibertyProteomics, Horluce BioConsulting, the Australian Proteome Analysis Facility, and Covaris.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.